Yeah not trying to be negative here, just looking at the facts keeping emotion out of it..
No doubt, bubs has made gains.
FDA approval will be in the bag imo however won’t make anything change… sales will still go on the same way.
CFO is retiring change can be good or bad. We won’t know.
China and USA market forecast 50% gains plausible as long as stock keeps up.
Personally I think this quarter will have strong sales results, judging Amazon.com USA sales don’t look good oct-Nov-Dec (just judging by Oct) Walmart looks strong but 100-200 cans per day. Unsure on retail floor.
New cans in Amazon bearly sold any compared to old cans, 2k cans for goat and cow alone
the up take hasn’t looked good nor is the stock situation.
I spent many hours on this horse but the facts are cash flow is running low and the money has to come from somewhere to keep the fire going.
Not to mention Court case coming up…
Too many Questions mark plus CR I’m out for now…
But will be watching closely… the boys of been calling it for a while.
If Sales continue I think bubs will still be worth something however I think they might be having difficulties with the new can uptake or supply’s. Which makes sense hearing from above.
As always DYOR, I for one will play this one safe..
Time will tell, I look forward to Jan 2nd half FY25 report
(20min delay)